SUN PHARMACEUTICAL INDUSTRIES
Back to Balance Sheet
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹15,510 Cr | ₹13,046 Cr | ₹11,249 Cr | ₹11,439 Cr | ₹10,485 Cr |
What is the latest Sundry Debtors ratio of SUN PHARMACEUTICAL INDUSTRIES ?
| Year | Sundry Debtors |
|---|---|
| Mar2026 | ₹15,510 Cr |
| Mar2025 | ₹13,046 Cr |
| Mar2024 | ₹11,249 Cr |
| Mar2023 | ₹11,439 Cr |
| Mar2022 | ₹10,485 Cr |
How is Sundry Debtors of SUN PHARMACEUTICAL INDUSTRIES Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2026 | ₹15,510 Cr | 18.88 | |
| Mar2025 | ₹13,046 Cr | 15.97 | |
| Mar2024 | ₹11,249 Cr | -1.65 | |
| Mar2023 | ₹11,439 Cr | 9.10 | |
| Mar2022 | ₹10,485 Cr | - | |
Compare Sundry Debtors of peers of SUN PHARMACEUTICAL INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,188.3 Cr | 1.8% | 9% | 12.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹180,823.0 Cr | 0.8% | 0.8% | -1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹165,725.0 Cr | 2.8% | 9.5% | 45.4% | Stock Analytics | |
| CIPLA | ₹116,467.0 Cr | -1.2% | 4.7% | -4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,987.0 Cr | -7.6% | 0.1% | 6.1% | Stock Analytics | |
| MANKIND PHARMA | ₹104,544.0 Cr | 0% | 5.9% | 4.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMACEUTICAL INDUSTRIES | 1.8% |
9% |
12.5% |
| SENSEX | -1% |
4.4% |
-8.3% |
You may also like the below Video Courses